Literature DB >> 17255343

Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis.

Maria I Harrell1, Brian M Iritani, Alanna Ruddell.   

Abstract

Lymphangiogenesis is associated with human and murine cancer metastasis, suggesting that lymphatic vessels are important for tumor dissemination. Lymphatic vessel alterations were examined using B16-F10 melanoma cells implanted in syngeneic C57Bl/6 mice, which form tumors metastasizing to draining lymph nodes and subsequently to the lungs. Footpad tumors showed no lymphatic or blood vessel growth; however, the tumor-draining popliteal lymph node featured greatly increased lymphatic sinuses. Lymph node lymphangiogenesis began before melanoma cells reached draining lymph nodes, indicating that primary tumors induce these alterations at a distance. Lymph flow imaging revealed that nanoparticle transit was greatly increased through tumor-draining relative to nondraining lymph nodes. Lymph node lymphatic sinuses and lymph flow were increased in mice implanted with unmarked or with foreign antigen-expressing melanomas, indicating that these effects are not due to foreign antigen expression. However, tumor-derived immune signaling could promote lymph node alterations, as macrophages infiltrated footpad tumors, whereas lymphocytes accumulated in tumor-draining lymph nodes. B lymphocytes are required for lymphangiogenesis and increased lymph flow through tumor-draining lymph nodes, as these alterations were not observed in mice deficient for B cells. Lymph node lymphangiogenesis and increased lymph flow through tumor-draining lymph nodes may actively promote metastasis via the lymphatics.

Entities:  

Mesh:

Year:  2007        PMID: 17255343      PMCID: PMC1851877          DOI: 10.2353/ajpath.2007.060761

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  52 in total

1.  The enhanced green fluorescent protein (eGFP) is minimally immunogenic in C57BL/6 mice.

Authors:  D Skelton; N Satake; D B Kohn
Journal:  Gene Ther       Date:  2001-12       Impact factor: 5.250

Review 2.  The physiology of the lymphatic system.

Authors:  M A Swartz
Journal:  Adv Drug Deliv Rev       Date:  2001-08-23       Impact factor: 15.470

3.  Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium.

Authors:  R Prevo; S Banerji; D J Ferguson; S Clasper; D G Jackson
Journal:  J Biol Chem       Date:  2001-02-20       Impact factor: 5.157

4.  Tumours can act as adjuvants for humoral immunity.

Authors:  D M Brown; T L Fisher; C Wei; J G Frelinger; E M Lord
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

5.  Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor.

Authors:  Markus Guba; Philipp von Breitenbuch; Markus Steinbauer; Gudrun Koehl; Stefanie Flegel; Matthias Hornung; Christiane J Bruns; Carl Zuelke; Stefan Farkas; Matthias Anthuber; Karl-Walter Jauch; Edward K Geissler
Journal:  Nat Med       Date:  2002-02       Impact factor: 53.440

6.  Blocked B cell differentiation and emigration support the early growth of Myc-induced lymphomas.

Authors:  K A Brandvold; D L Ewert; S C Kent; P Neiman; A Ruddell
Journal:  Oncogene       Date:  2001-05-31       Impact factor: 9.867

7.  Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.

Authors:  Yulong He; Ken-Ichi Kozaki; Terhi Karpanen; Katsumi Koshikawa; Seppo Yla-Herttuala; Takashi Takahashi; Kari Alitalo
Journal:  J Natl Cancer Inst       Date:  2002-06-05       Impact factor: 13.506

8.  Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis.

Authors:  S J Mandriota; L Jussila; M Jeltsch; A Compagni; D Baetens; R Prevo; S Banerji; J Huarte; R Montesano; D G Jackson; L Orci; K Alitalo; G Christofori; M S Pepper
Journal:  EMBO J       Date:  2001-02-15       Impact factor: 11.598

9.  Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis.

Authors:  M Skobe; T Hawighorst; D G Jackson; R Prevo; L Janes; P Velasco; L Riccardi; K Alitalo; K Claffey; M Detmar
Journal:  Nat Med       Date:  2001-02       Impact factor: 53.440

10.  Onset of abnormal blood and lymphatic vessel function and interstitial hypertension in early stages of carcinogenesis.

Authors:  Jeroen Hagendoorn; Ricky Tong; Dai Fukumura; Qingcong Lin; Jennifer Lobo; Timothy P Padera; Lei Xu; Raju Kucherlapati; Rakesh K Jain
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

View more
  151 in total

1.  In vivo imaging of lymphatic vessels in development, wound healing, inflammation, and tumor metastasis.

Authors:  Inés Martínez-Corral; David Olmeda; Rodrigo Diéguez-Hurtado; Tuomas Tammela; Kari Alitalo; Sagrario Ortega
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

Review 2.  Current views on the function of the lymphatic vasculature in health and disease.

Authors:  Yingdi Wang; Guillermo Oliver
Journal:  Genes Dev       Date:  2010-10-01       Impact factor: 11.361

Review 3.  Preclinical lymphatic imaging.

Authors:  Fan Zhang; Gang Niu; Guangming Lu; Xiaoyuan Chen
Journal:  Mol Imaging Biol       Date:  2011-08       Impact factor: 3.488

4.  Optical clearing based cellular-level 3D visualization of intact lymph node cortex.

Authors:  Eunjoo Song; Howon Seo; Kibaek Choe; Yoonha Hwang; Jinhyo Ahn; Soyeon Ahn; Pilhan Kim
Journal:  Biomed Opt Express       Date:  2015-09-28       Impact factor: 3.732

Review 5.  The lymphatic system and pancreatic cancer.

Authors:  Darci M Fink; Maria M Steele; Michael A Hollingsworth
Journal:  Cancer Lett       Date:  2015-12-29       Impact factor: 8.679

6.  Melanoma growth effects on molecular clearance from tumors and biodistribution into systemic tissues versus draining lymph nodes.

Authors:  Nathan Andrew Rohner; Susan Napier Thomas
Journal:  J Control Release       Date:  2015-12-23       Impact factor: 9.776

7.  In vivo imaging of inflammation- and tumor-induced lymph node lymphangiogenesis by immuno-positron emission tomography.

Authors:  Viviane Mumprecht; Michael Honer; Benjamin Vigl; Steven T Proulx; Eveline Trachsel; Manuela Kaspar; Nadja E Banziger-Tobler; Roger Schibli; Dario Neri; Michael Detmar
Journal:  Cancer Res       Date:  2010-10-26       Impact factor: 12.701

8.  Imaging of the Mouse Lymphatic Sinus during Early Stage Lymph Node Metastasis Using Intranodal Lymphangiography with X-ray Micro-computed Tomography.

Authors:  Ryo Iwamura; Maya Sakamoto; Shiro Mori; Tetsuya Kodama
Journal:  Mol Imaging Biol       Date:  2019-10       Impact factor: 3.488

9.  Adrenomedullin gene dosage correlates with tumor and lymph node lymphangiogenesis.

Authors:  Natalie O Karpinich; Daniel O Kechele; Scott T Espenschied; Helen H Willcockson; Yuri Fedoriw; Kathleen M Caron
Journal:  FASEB J       Date:  2012-10-25       Impact factor: 5.191

10.  Impaired humoral immunity and tolerance in K14-VEGFR-3-Ig mice that lack dermal lymphatic drainage.

Authors:  Susan N Thomas; Joseph M Rutkowski; Miriella Pasquier; Emma L Kuan; Kari Alitalo; Gwendalyn J Randolph; Melody A Swartz
Journal:  J Immunol       Date:  2012-07-27       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.